Literature DB >> 9588184

Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease.

M Honda1, H Akiyama, Y Yamada, H Kondo, Y Kawabe, M Takeya, K Takahashi, H Suzuki, T Doi, A Sakamoto, S Ookawara, M Mato, P J Gough, D R Greaves, S Gordon, T Kodama, M Matsushita.   

Abstract

Macrophage scavenger receptors (MSR) are implicated in the development of atherosclerosis and amyloid b-protein deposition in Alzheimer's disease. However, histopathological studies of MSR expression in human tissues have been hampered by a lack of specific antibodies. Using MSR-deficient mice, we successfully raised a novel monoclonal antibody against human MSR together with high-titer antisera. These antibodies specifically recognized human tissue macrophages and human MSR protein purified from differentiated THP1 cells. In normal brain, MSR staining was mainly distributed to the perivascular cells, which correspond to Mato's fluorescent granular perithelial cells (Mato cells). In the lesions of ischemia and Alzheimer's disease, a subset of microglia stained positive for MSR. These novel antibodies are useful tools for analysis of MSR expression in human tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9588184     DOI: 10.1006/bbrc.1998.8120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Expression of scavenger receptor class B, type I, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's disease brain.

Authors:  J Husemann; S C Silverstein
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

Review 2.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

3.  CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.

Authors:  Indra Sethy Coraci; Jens Husemann; Joan W Berman; Christine Hulette; Jennifer H Dufour; Gabriele K Campanella; Andrew D Luster; Samuel C Silverstein; Joseph B El-Khoury
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 4.  Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.

Authors:  Ahsan Habib; Darrell Sawmiller; Jun Tan
Journal:  J Neurosci Res       Date:  2016-08-17       Impact factor: 4.164

Review 5.  Chromogranin peptides in brain diseases.

Authors:  Michael Willis; Irmgard Leitner; Kurt A Jellinger; Josef Marksteiner
Journal:  J Neural Transm (Vienna)       Date:  2011-04-30       Impact factor: 3.575

6.  Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-β.

Authors:  Ling Guo; Aras Rezvanian; Lokesh Kukreja; Ramez Hoveydai; Eileen H Bigio; M-Marsel Mesulam; Joseph El Khoury; Changiz Geula
Journal:  J Alzheimers Dis       Date:  2016-10-04       Impact factor: 4.472

7.  Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.

Authors:  Galina K Sukhova; Yaou Zhang; Jie-Hong Pan; Youichiro Wada; Takashi Yamamoto; Makoto Naito; Tatsuhiko Kodama; Sotirios Tsimikas; Joseph L Witztum; Michael L Lu; Yasuhiko Sakara; Michael T Chin; Peter Libby; Guo-Ping Shi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  The role of macrophage scavenger receptor 1 (Msr1) in prion pathogenesis.

Authors:  Bei Li; Meiling Chen; Adriano Aguzzi; Caihong Zhu
Journal:  J Mol Med (Berl)       Date:  2021-03-23       Impact factor: 4.599

Review 9.  Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease.

Authors:  Francisca Cornejo; Rommy von Bernhardi
Journal:  Mediators Inflamm       Date:  2013-05-07       Impact factor: 4.711

10.  CD36 mediates the innate host response to beta-amyloid.

Authors:  Joseph B El Khoury; Kathryn J Moore; Terry K Means; Josephine Leung; Kinya Terada; Michelle Toft; Mason W Freeman; Andrew D Luster
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.